Release Date: 10/09/13 16:31 Summary: Final Director's Interest Notice Price Sensitive: No Download Document 59.73KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%